| Effects of codon usage versus putative 5′-mRNA structure on the expression of Fusarium solani cutinase in the Escherichia coli cytoplasm KE Griswold, NA Mahmood, BL Iverson, G Georgiou Protein expression and purification 27 (1), 134-142, 2003 | 146 | 2003 |
| Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy JW Lamppa, KE Griswold Antimicrobial agents and chemotherapy 57 (1), 137-145, 2013 | 133 | 2013 |
| A high‐throughput screen for antibiotic drug discovery TC Scanlon, SM Dostal, KE Griswold Biotechnology and bioengineering 111 (2), 232-243, 2014 | 121 | 2014 |
| Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion X Zhang, DB Reeves, IM Perreard, WC Kett, KE Griswold, B Gimi, ... Biosensors and Bioelectronics 50, 441-446, 2013 | 107 | 2013 |
| Enhanced crossover SCRATCHY: construction and high‐throughput screening of a combinatorial library containing multiple non‐homologous crossovers Y Kawarasaki, KE Griswold, JD Stevenson, T Selzer, SJ Benkovic, ... Nucleic acids research 31 (21), e126-e126, 2003 | 92 | 2003 |
| The monoclonal myth TC Scanlon, HL Jewell, EC Gray, KE Griswold Bioengineered Bugs 1 (3), 225-228, 2010 | 90 | 2010 |
| Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization M Levy, KE Griswold, AD Ellington Rna 11 (10), 1555-1562, 2005 | 85 | 2005 |
| Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo C NDong, JA Tate, WC Kett, J Batra, E Demidenko, LD Lewis, PJ Hoopes, ... PloS one 10 (2), e0115636, 2015 | 81 | 2015 |
| Evolution of highly active enzymes by homology-independent recombination KE Griswold, Y Kawarasaki, N Ghoneim, SJ Benkovic, BL Iverson, ... Proceedings of the National Academy of Sciences 102 (29), 10082-10087, 2005 | 69 | 2005 |
| Structure-guided deimmunization of therapeutic proteins AS Parker, Y Choi, KE Griswold, C Bailey-Kellogg Journal of Computational Biology 20 (2), 152-165, 2013 | 66 | 2013 |
| Optimization algorithms for functional deimmunization of therapeutic proteins AS Parker, W Zheng, KE Griswold, C Bailey-Kellogg BMC bioinformatics 11, 1-15, 2010 | 63 | 2010 |
| Design and engineering of deimmunized biotherapeutics KE Griswold, C Bailey-Kellogg Current opinion in structural biology 39, 79-88, 2016 | 61 | 2016 |
| Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo H Zhao, D Verma, W Li, Y Choi, C Ndong, SN Fiering, C Bailey-Kellogg, ... Chemistry & biology 22 (5), 629-639, 2015 | 60 | 2015 |
| The evolution of catalytic efficiency and substrate promiscuity in human theta class 1-1 glutathione transferase KE Griswold, NS Aiyappan, BL Iverson, G Georgiou Journal of molecular biology 364 (3), 400-410, 2006 | 58 | 2006 |
| Design and analysis of immune-evading enzymes for ADEPT therapy DC Osipovitch, AS Parker, CD Makokha, J Desrosiers, WC Kett, L Moise, ... Protein Engineering, Design & Selection 25 (10), 613-624, 2012 | 57 | 2012 |
| Enhanced antimicrobial activity of engineered human lysozyme TC Scanlon, CC Teneback, A Gill, JL Bement, JA Weiner, JW Lamppa, ... ACS chemical biology 5 (9), 809-818, 2010 | 55 | 2010 |
| Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity JW Lamppa, ME Ackerman, JI Lai, TC Scanlon, KE Griswold PloS one 6 (2), e17042, 2011 | 47 | 2011 |
| Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity DC Osipovitch, S Therrien, KE Griswold Applied microbiology and biotechnology 99, 6315-6326, 2015 | 45 | 2015 |
| Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris H Zhao, K Blazanovic, Y Choi, C Bailey-Kellogg, KE Griswold Applied and environmental microbiology 80 (9), 2746-2753, 2014 | 45 | 2014 |
| Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance K Blazanovic, H Zhao, Y Choi, W Li, RS Salvat, DC Osipovitch, J Fields, ... Molecular therapy Methods & clinical development 2, 2015 | 44 | 2015 |